Enzymes Sustainable Alternatives with Remarkable Scope

We are sorry but this premium report expired!

This market research, not available anymore on the publisher's website, was withdrawn from our database.

To get an alternative report, you can either :

  • Have a look at the list of documents hereafter
  • Launch a new search below

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

DOWNLOAD THESE REPORTS NOW!

Bio Products Markets in China

Bio Products Markets in China

  • $ 4 000
  • Industry report
  • by Asia Market Information & Development Company
  • November 2014
  • 349 pages

China's demand for Bio Products has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption ...

Industries: Biopharmaceutical | Countries: China

Taigen Biopharmaceuticals Holdings Ltd

Taigen Biopharmaceuticals Holdings Ltd

  • $ 55
  • Company report
  • by Wright Investors' Service
  • October 2014
  • 53 pages

A textual analysis of the financial results for Taigen Biopharmaceuticals Holdings Ltd compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security pricing. ...

Industries: Biopharmaceutical

Epirus Biopharmaceuticals Inc

Epirus Biopharmaceuticals Inc

  • $ 55
  • Company report
  • by Wright Investors' Service
  • October 2014
  • 56 pages

A textual analysis of the financial results for Epirus Biopharmaceuticals Inc compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security pricing. A business ...

Industries: Biopharmaceutical

Natraj Proteins Limited

Natraj Proteins Limited

  • $ 55
  • Company report
  • by Wright Investors' Service
  • October 2014
  • 53 pages

A textual analysis of the financial results for Natraj Proteins Limited compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security pricing. A business description ...

Industries: Biopharmaceutical

Solco Biomedical Co Ltd

Solco Biomedical Co Ltd

  • $ 55
  • Company report
  • by Wright Investors' Service
  • October 2014
  • 57 pages

A textual analysis of the financial results for Solco Biomedical Co Ltd compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security pricing. A business description ...

Industries: Biopharmaceutical

Rasoya Proteins Ltd

Rasoya Proteins Ltd

  • $ 55
  • Company report
  • by Wright Investors' Service
  • October 2014
  • 54 pages

A textual analysis of the financial results for Rasoya Proteins Ltd compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security pricing. A business description ...

Industries: Biopharmaceutical

Sino Biopharmaceutical Limited

Sino Biopharmaceutical Limited

  • $ 55
  • Company report
  • by Wright Investors' Service
  • October 2014
  • 56 pages

A textual analysis of the financial results for Sino Biopharmaceutical Limited compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security pricing. A business ...

Industries: Biopharmaceutical | Countries: China

Response Biomedical Corp.

Response Biomedical Corp.

  • $ 55
  • Company report
  • by Wright Investors' Service
  • October 2014
  • 56 pages

A textual analysis of the financial results for Response Biomedical Corp. compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security pricing. A business ...

Industries: Biopharmaceutical

Global and China Monoclonal Antibody Industry Report, 2014-2019

Global and China Monoclonal Antibody Industry Report, 2014-2019

  • $ 2 600
  • Industry report
  • by Research In China
  • October 2014
  • 136 pages

Despite world-wide economic downturn and great changes in exchange rate, benefiting from robust market demand, global monoclonal antibody market size exceeded USD 80 billion in 2013, still one of biotech drugs with the fastest CAGR in recent years. Global blockbuster monoclonal antibody agents are still ...

Industries: Biopharmaceutical | Countries: China

Physician Views: Biosimilar Lucentis - what opportunity?

Physician Views: Biosimilar Lucentis - what opportunity?

  • $ 645
  • Industry report
  • by Firstword Pharma
  • October 2014

With the initial focus of biosimilar antibody developers very much sharpened on the markets for TNF inhibitors (Remicade, Humira) and leading cancer MAbs (Herceptin, Rituxan, Avastin), the opportunity for biosimilar Lucentis, for the treatment of wet age-related macular degeneration (AMD) has been ...

Industries: Biopharmaceutical | Countries: United States

24/7 Customer Service

You can call our customer service 24 hours a day / 7 days a week

  • +1 339 368 6001

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.